Related Experiment Video
Updated: Apr 1, 2026

07:39
An In vitro Co-infection Model to Study Plasmodium falciparum-HIV-1 Interactions in Human Primary Monocyte-derived Immune Cells
Published on: August 15, 2012
14.3K
DMPA use and HIV acquisition: time to switch to NET-EN?
Heidi E Jones1, Janneke H H M van de Wijgert2
1City University of New York School of Public Health and Hunter College, New York, NY 10035, USA.
The Lancet. HIV
|October 2, 2015
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Intrauterine Drug Delivery Systems
129
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
129
Therapeutic Drug Monitoring: Affecting Factors
334
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
334

